# FDA-mid
Conducted a technical analysis of FTX’s rapid growth and collapse, highlighting critical failures like lack of audits, risky token overexposure, and $10B+ misused customer funds. Examined Binance’s FTT sell-off triggering insolvency and the resulting legal actions, emphasizing the need for stronger governance and regulation in crypto markets.
